Ticker Symbol | Entity Name | Employer Id | As Of Date | Profile Url | Name | Website | Company Type | Industry | Active Status | Employer Status | Headquarters City | Year Founded | Rating: Overall | Rating: CEO (%) | Rating: Business Outlook (%) | Rating: Recommend (%) | Rating: Compensation & Benefits | Rating: Culture & Values | Rating: Career Opportunities | Rating: Diversity and Inclusion | Rating: Work/Life Balance | Rating: Senior Management | Ratings Star 1 Count | Ratings Star 2 Count | Ratings Star 3 Count | Ratings Star 4 Count | Ratings Star 5 Count | Ratings Count | Ratings Diversity and Inclusion Count | Ratings CEO Count | Ratings Star 1 (%) | Ratings Star 2 (%) | Ratings Star 3 (%) | Ratings Star 4 (%) | Ratings Star 5 (%) | Awards Count | Job Count | Review Count | Interview Experience: Positive | Interview Experience: Neutral | Interview Experience: Negative | Interview Channel: Online (%) | Interview Channel: Campus Recruiting | Interview Channel: Recruiter | Interview Channel: Employee Referral | Interview Channel: Staffing Agency | Interview Channel: In-Person | Interview Channel: Other | CEO Profile Image | CEO | Date Added | Date Updated | Company Name | Sector | Industry | CEO Gender | CEO Ethnicity |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
tyo:4503 | https://www.glassdoor.com?employer_id=38616 | 38616 | Apr 28th, 2024 12:00AM | Open | Astellas Pharma US | Open | Company - Public | Biotech & Pharmaceuticals | Northbrook, IL | 2005 | 4.10 | 85% | 59% | 79% | 4.20 | 3.90 | 3.60 | 4.10 | 4.00 | 3.60 | 8.00 | 3.00 | 16.00 | 31.00 | 43.00 | 101.00 | 130.00 | 104.00 | 7.921% | 2.97% | 15.842% | 30.693% | 42.574% | 28.00 | 417.00 | 0.53 | 0.15 | 0.32 | 0.63 | 0.16 | 0.11 | 0.02 | 0.02 | 0.02 | Kenji Yasukawa | Apr 28th, 2024 05:39PM | Apr 28th, 2024 05:39PM | Astellas Pharma | |||||||||
tyo:4503 | https://www.glassdoor.com?employer_id=1152419 | 1152419 | Apr 28th, 2024 12:00AM | Open | Astellas Gene Therapies | Open | Subsidiary or Business Segment | Biotech & Pharmaceuticals | San Francisco, CA | 2012 | 3.80 | 100% | 73% | 72% | 4.50 | 3.80 | 3.80 | 4.10 | 4.10 | 3.20 | 3.00 | 2.00 | 4.00 | 5.00 | 8.00 | 22.00 | 24.00 | 9.00 | 13.636% | 9.091% | 18.182% | 22.727% | 36.364% | 0.00 | 0.00 | 52.00 | 0.50 | 0.30 | 0.20 | 0.67 | 0.33 | Kenji Yasukawa | Apr 28th, 2024 05:39PM | Apr 28th, 2024 05:39PM | Astellas Pharma | ||||||||||||
tyo:4503 | https://www.glassdoor.com?employer_id=38616 | 38616 | Apr 26th, 2024 12:00AM | Open | Astellas Pharma US | Open | Company - Public | Biotech & Pharmaceuticals | Northbrook, IL | 2005 | 4.10 | 85% | 59% | 79% | 4.20 | 3.90 | 3.60 | 4.10 | 4.00 | 3.60 | 7.00 | 3.00 | 17.00 | 31.00 | 43.00 | 101.00 | 130.00 | 104.00 | 6.931% | 2.97% | 16.832% | 30.693% | 42.574% | 28.00 | 416.00 | 0.53 | 0.15 | 0.32 | 0.63 | 0.16 | 0.11 | 0.02 | 0.02 | 0.02 | Kenji Yasukawa | Apr 26th, 2024 09:26AM | Apr 26th, 2024 09:26AM | Astellas Pharma | |||||||||
tyo:4503 | https://www.glassdoor.com?employer_id=1152419 | 1152419 | Apr 26th, 2024 12:00AM | Open | Astellas Gene Therapies | Open | Subsidiary or Business Segment | Biotech & Pharmaceuticals | San Francisco, CA | 2012 | 3.80 | 100% | 73% | 72% | 4.50 | 3.80 | 3.80 | 4.10 | 4.10 | 3.20 | 3.00 | 2.00 | 4.00 | 5.00 | 8.00 | 22.00 | 24.00 | 9.00 | 13.636% | 9.091% | 18.182% | 22.727% | 36.364% | 0.00 | 0.00 | 52.00 | 0.50 | 0.30 | 0.20 | 0.67 | 0.33 | Kenji Yasukawa | Apr 26th, 2024 09:26AM | Apr 26th, 2024 09:26AM | Astellas Pharma | ||||||||||||
tyo:4503 | https://www.glassdoor.com?employer_id=38616 | 38616 | Apr 25th, 2024 12:00AM | Open | Astellas Pharma US | Open | Company - Public | Biotech & Pharmaceuticals | Northbrook, IL | 2005 | 4.10 | 85% | 59% | 79% | 4.20 | 3.90 | 3.60 | 4.10 | 4.00 | 3.60 | 7.00 | 3.00 | 17.00 | 31.00 | 43.00 | 101.00 | 130.00 | 104.00 | 6.931% | 2.97% | 16.832% | 30.693% | 42.574% | 28.00 | 416.00 | 0.53 | 0.15 | 0.32 | 0.63 | 0.16 | 0.11 | 0.02 | 0.02 | 0.02 | Kenji Yasukawa | Apr 25th, 2024 07:51PM | Apr 25th, 2024 07:51PM | Astellas Pharma | |||||||||
tyo:4503 | https://www.glassdoor.com?employer_id=1152419 | 1152419 | Apr 25th, 2024 12:00AM | Open | Astellas Gene Therapies | Open | Subsidiary or Business Segment | Biotech & Pharmaceuticals | San Francisco, CA | 2012 | 3.80 | 100% | 73% | 72% | 4.50 | 3.80 | 3.80 | 4.10 | 4.10 | 3.20 | 3.00 | 2.00 | 4.00 | 5.00 | 8.00 | 22.00 | 24.00 | 9.00 | 13.636% | 9.091% | 18.182% | 22.727% | 36.364% | 0.00 | 0.00 | 52.00 | 0.50 | 0.30 | 0.20 | 0.67 | 0.33 | Kenji Yasukawa | Apr 25th, 2024 07:51PM | Apr 25th, 2024 07:51PM | Astellas Pharma | ||||||||||||
tyo:4503 | https://www.glassdoor.com?employer_id=1152419 | 1152419 | Apr 24th, 2024 12:00AM | Open | Astellas Gene Therapies | Open | Subsidiary or Business Segment | Biotech & Pharmaceuticals | San Francisco, CA | 2012 | 3.80 | 100% | 73% | 72% | 4.50 | 3.80 | 3.80 | 4.10 | 4.10 | 3.20 | 3.00 | 2.00 | 4.00 | 5.00 | 8.00 | 22.00 | 24.00 | 9.00 | 13.636% | 9.091% | 18.182% | 22.727% | 36.364% | 0.00 | 0.00 | 52.00 | 0.50 | 0.30 | 0.20 | 0.67 | 0.33 | Kenji Yasukawa | Apr 24th, 2024 12:22PM | Apr 24th, 2024 12:22PM | Astellas Pharma | ||||||||||||
tyo:4503 | https://www.glassdoor.com?employer_id=38616 | 38616 | Apr 24th, 2024 12:00AM | Open | Astellas Pharma US | Open | Company - Public | Biotech & Pharmaceuticals | Northbrook, IL | 2005 | 4.10 | 85% | 59% | 79% | 4.20 | 3.90 | 3.60 | 4.10 | 4.00 | 3.60 | 7.00 | 3.00 | 17.00 | 31.00 | 43.00 | 101.00 | 130.00 | 104.00 | 6.931% | 2.97% | 16.832% | 30.693% | 42.574% | 28.00 | 416.00 | 0.53 | 0.15 | 0.31 | 0.63 | 0.16 | 0.11 | 0.02 | 0.02 | 0.02 | Kenji Yasukawa | Apr 24th, 2024 12:22PM | Apr 24th, 2024 12:22PM | Astellas Pharma | |||||||||
tyo:4503 | https://www.glassdoor.com?employer_id=38616 | 38616 | Apr 23rd, 2024 12:00AM | Open | Astellas Pharma US | Open | Company - Public | Biotech & Pharmaceuticals | Northbrook, IL | 2005 | 4.10 | 85% | 59% | 79% | 4.20 | 3.90 | 3.60 | 4.10 | 4.00 | 3.60 | 7.00 | 3.00 | 17.00 | 31.00 | 43.00 | 101.00 | 130.00 | 104.00 | 6.931% | 2.97% | 16.832% | 30.693% | 42.574% | 28.00 | 416.00 | 0.53 | 0.15 | 0.31 | 0.63 | 0.16 | 0.11 | 0.02 | 0.02 | 0.02 | Kenji Yasukawa | Apr 23rd, 2024 05:44PM | Apr 23rd, 2024 05:44PM | Astellas Pharma | |||||||||
tyo:4503 | https://www.glassdoor.com?employer_id=1152419 | 1152419 | Apr 23rd, 2024 12:00AM | Open | Astellas Gene Therapies | Open | Subsidiary or Business Segment | Biotech & Pharmaceuticals | San Francisco, CA | 2012 | 3.80 | 100% | 73% | 72% | 4.50 | 3.80 | 3.80 | 4.10 | 4.10 | 3.20 | 3.00 | 2.00 | 4.00 | 5.00 | 8.00 | 22.00 | 24.00 | 9.00 | 13.636% | 9.091% | 18.182% | 22.727% | 36.364% | 0.00 | 0.00 | 52.00 | 0.50 | 0.30 | 0.20 | 0.67 | 0.33 | Kenji Yasukawa | Apr 23rd, 2024 05:44PM | Apr 23rd, 2024 05:44PM | Astellas Pharma |